Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aqtual, Edap Tms, Icecure, Setpoint.

Med-tech firms raising money in public or private financings, including: Augere, Cytomos, Spectral AI, Zenflow.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alpha Imaging, Astrazeneca, Daiichi Sankyo, Fresneius, Grail, Nephro Group, Radon Medical, Rockwell Medical, Telix..

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Biogen, Neurizon, Recce, Samsung.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Everest, Immutep, Lixa.

New hires and promotions in biopharma in Asia-Pacific, including: Opthea.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: ARS, Alk-Abello, Alfreso, Atsena, Biocytogen, Biontech, Biotheus, CSL, Ideaya, Kaken, Nippon Shinyaku, NS Pharma, Numab, Pediatrix, Qilu, Theravance, Viatris

Biopharmas in Asia-Pacific raising money in public or private financings: Zai Lab.

Med-tech firms raising money in public or private financings, including: Quanta.

The top 10 med-tech stock gainers and losers for the week.